SUBSCRIBE
FIRM RECORD
William Blair
.
10 deals in the register, newest first — each row labelled with the firm's role.
HIG / Outcomes One
BUY SIDE
2026-09-02
Pharmacy management software, clinical network, and patient engagement platform serving pharmacies, health plans, pharmaceutical manufacture
Maguar Capital Partners / Schlafender Hase
SELL SIDE
2026-08-18
Deterministic content verification and proofreading software for pharmaceutical and medical device companies, automating error detection in
Thoma Bravo / Padoa
BUY SIDE
2026-08-11
Occupational health, safety, and prevention software platform serving occupational health centres, employers, and employees with tools for s
365 Retail Markets / Cantaloupe, Inc
BUY SIDE
2026-08-10
Self-service technology and payments software for unattended retail, vending, and micro-market operators.
RedSail Technologies / PrimeRx
SELL SIDE
2026-02-01
PrimeRx provides end-to-end pharmacy management software automating prescription processing, billing, inventory, and clinical workflows for
Bain Capital / HST Pathways
SELL SIDE
2026-02-01
HST Pathways delivers a cloud-based suite of EHR, scheduling, billing, and analytics software purpose-built for ambulatory surgery centers.
TechnoMile / SIMS Software
SELL SIDE
2026-01-01
SIMS Software automates tracking of personnel security clearances, classified information, and facility compliance for government agencies a
Insight Partners / SpryPoint
SELL SIDE
2026-01-01
SpryPoint provides cloud-native customer information, billing, and field-operations software to electric, water, gas, and telecom utilities
TPG / Trustwell
SELL SIDE
2026-01-01
Supply chain software purpose-built for the food industry.
WindRose Health Investors / Avalon Healthcare Solutions
SELL SIDE
2026-01-01
Avalon's Diagnostic Insights Platform manages routine and genetic lab test benefits, enforcing evidence-based clinical policies in real time
Claim a missing credit or send a correction
.
PAST ISSUES
CONTACT
© 2026 Thematic |
Privacy Policy
|
Terms of Service
Thematic is a news publication, not an investment adviser. Nothing here is investment advice or a recommendation to buy or sell any security. Researched and compiled by Thematic; accuracy and completeness are not guaranteed.